In 2022, 29.5 million Americans ages 12 or older had alcohol use disorder (AUD). Less than 8% of those with AUD received any form of treatment in the last year and only 2.1% received medication to treat alcohol use disorder (MAUD). This webinar hosted by the Providers Clinical Support System – Medications for Alcohol Use Disorder (PCSS-MAUD) will highlight the prevalence of alcohol use in the region while providing skills to identify, diagnose, and treat AUD with an emphasis on using the three FDA-approved MAUD. Screening, withdrawal management, and a conversation about challenging cases will also be included. All healthcare professionals are encouraged to attend this webinar.

Learning Objectives

• Explain prevalence, nomenclature, and diagnostic criteria for alcohol use disorder.
• Describe the three FDA-approved medications for alcohol use disorder and how best to determine a medication regimen.
• Demonstrate how to assess risk for alcohol withdrawal syndrome and determine a treatment plan based on risk.

Dr. Brian Fuehrlein graduated from the M.D. Ph.D. program at the University of Florida in 2008, adult psychiatry residency program at the University of Texas Southwestern Medical Center in 2012 and addiction psychiatry fellowship at Yale University in 2013. He is currently an Associate Professor and the director of the psychiatric emergency room at the VA Connecticut. Dr. Fuehrlein has a strong interest in medical student and resident education, particularly surrounding addiction psychiatry and serves on multiple local and national committees in this role.